Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Clinical trial NCT01884961 · COMPLETED

Trial details

NCT number: NCT01884961
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Cancer Malignant Melanoma, Metastatic

Start date: 2012-07-09
Primary completion: 2021-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.